Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study.

@article{Naumovic2010CyclosporineVA,
  title={Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study.},
  author={Radomir T Naumovic and Dijana Jovanovi{\'c} and Stevan Pavlovi{\'c} and Milan D Stosovi{\'c} and Jelena Marinkovi{\'c} and Gordana M Basta-Jovanovic},
  journal={Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie},
  year={2010},
  volume={65 2},
  pages={
          105-10
        }
}
There is no consensus regarding the modality of therapy for idiopathic membranous nephropathy (IMN), especially for patients who did not react to treatment with cytotoxic drugs. This study followed prospectively for 3-year IMN patients who did not react to Ponticelli protocol comparing effects of 2-year course of cyclosporine (CsA) with azathioprine (Aza) treatment both with small doses of prednisolone. Twenty-three patients were randomly assigned to receive either cyclosporine at 3mg/kg per… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-9 OF 9 CITATIONS

Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials.

  • Clinical journal of the American Society of Nephrology : CJASN
  • 2013
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Membranous nephropathy: a review on the pathogenesis, diagnosis, and treatment.

  • Journal of the Formosan Medical Association = Taiwan yi zhi
  • 2015
VIEW 1 EXCERPT
CITES BACKGROUND

Membranöse Glomerulonephritis

  • Der Nephrologe
  • 2015
VIEW 1 EXCERPT
CITES BACKGROUND

Treatment of idiopathic membranous nephropathy.

  • Journal of the American Society of Nephrology : JASN
  • 2012